| 000 | 00859 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250512232044.0 | ||
| 264 | 0 | _c19830617 | |
| 008 | 198306s 0 0 eng d | ||
| 022 | _a0277-0008 | ||
| 024 | 7 |
_a10.1002/j.1875-9114.1982.tb03183.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPolk, R E | |
| 245 | 0 | 0 |
_aThird generation cephalosporins: possible impact upon pharmacy practice. _h[electronic resource] |
| 260 |
_bPharmacotherapy _c |
||
| 300 |
_a172-3 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Editorial | ||
| 650 | 0 | 4 |
_aCephalosporins _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPharmacy Service, Hospital |
| 773 | 0 |
_tPharmacotherapy _gvol. 2 _gno. 4 _gp. 172-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/j.1875-9114.1982.tb03183.x _zAvailable from publisher's website |
| 999 |
_c6762983 _d6762983 |
||